PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues
Theranostics (therapy + diagnosis) targeting prostate-specific membrane antigen (PSMA) is an emerging therapeutic modality that could alter treatment strategies for prostate cancer. Although PSMA-targeted radioligand therapy (PSMA-RLT) has a highly therapeutic effect on PSMA-positive tumor tissue, t...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2023-08-01
|
| Seria: | Current Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/1718-7729/30/8/529 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|